Company: SHPH
Filing Date: 2025-04-21
Form Type: DEFR14A
Source: 0001641172-25-005474
Chunk: 12

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-04-21
Form: DEFR14A
Chunk 12
---
 and on committees of the Board of Directors. The Nominating and Corporate Governance Committee further serves to advise the Board of Directors with respect to the Board of Directors’ composition, procedures and establishment of committees, as needed, to develop and recommend to the Board of Directors corporate governance principles applicable to the Company, and to oversee the evaluation of the Board of Directors and management. The Nominating and Corporate Governance Committee will consider stockholder recommendations for candidates for the Board of Directors in the same manner it considers nominees from other sources. Our Board of Directors retains the ultimate authority to nominate a candidate for election by the stockholders as a director or to fill any vacancy that may occur. In identifying prospective director candidates, the Nominating and Corporate Governance Committee may consider all facts and circumstances that it deems appropriate or advisable, including, among other things, the skills of the prospective director candidate, his or her depth and breadth of business experience or other background characteristics, his or her independence and the needs of the Board of Directors. All members of the Nominating and Corporate Governance Committee are independent directors. A copy of our Nominating and Corporate Governance Committee Charter is located under the “Investor Relations-Governance” tab on our website at www.shuttlepharma.com.

Audit Committee

| MEMBERS                    |     | MEETINGS               
 HELD IN 2024: 5*       
 ACTIONS                
 BY WRITTEN CONSENT: 2* |
| Steve                      
 Richards, MBA, CPA (Chair) |     |                        |
| George                     
 Scorsis                    |     |                        |
| Oleh                       
 Nabyt                      |     |                        |

The Audit Committee of our Board of Directors is our standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act.

* Messrs. Scorsis and Nabyt joined as the Company’s Board in February 2025. Accordingly, our previous Audit Committee members participated in the Audit Committee meetings held in 2024, or took action by written consent in 2024, until their resignations in February 2025.

| 8 |

KEY RESPONSIBILITIES

| ● | Reviews                                                                                                                               
 and discusses the financial statements for the financial year ended.                                                                  |
|:--|:--------------------------------------------------------------------------------------------------------------------------------------|
| ● | Oversees                                                                                                                              
 the accounting and financial reporting processes of the Company and the audits of the financial statements of the Company.            |
| ● | Discusses                                                                                                                             
 with the Company’s independent accountants the matters